您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Urolithin A
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Urolithin A
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Urolithin A图片
CAS NO:1143-70-0
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍

化学性质

StorageStore at -20°C
M.Wt228.20
Cas No.1143-70-0
FormulaC13H8O4
Solubility≥22.8 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
Chemical Name3,8-dihydroxy-6H-benzo[c]chromen-6-one
Canonical SMILESOC1=CC(C2=O)=C(C3=C(O2)C=C(O)C=C3)C=C1
运输条件蓝冰运输或根据您的需求运输。
一般建议为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

资料参考

Urolithin A is a microflora-derived metabolite [1].

Urolithin A is a natural food metabolite that stimulates mitophagy and reduces the accumulation of dysfunctional mitochondria with age, thus maintaining mitochondrial biogenesis and respiratory capacity in cells [1]. Urolithin A is the most active and effective gut metabolite that acts as a potent anti-inflammatory and anti-oxidant agent [2].

In CD4+ T cells, treatment of murine CD4+ T cells with Urolithin A (10 μM, 3 days) significantly blunted store operated Ca2+ entry (SOCE), which was accompanied by significant downregulation of STIM1/2 and Orai1 transcript levels and protein abundance. In addition, urolithin A treatment (5, 10, 20, 50 μM) further increased miR-10a-5p abundance in CD4+ T cells, in a dose-dependent manner [2].

In healthy, sedentary elderly individuals, 4 weeks of oral treatment with urolithin A at doses of 500 mg and 1000 mg modulated plasma acylcarnitines and skeletal muscle mitochondrial gene expression, with favourable safety profiles [1].

References:

[1]. Pénélope A. Andreux, Blanco-Bose W, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism, 2019, 1: 595-603.

[2]. Zhang S, Al-Maghout T, Cao H, et al. Gut Bacterial Metabolite Urolithin A (UA) Mitigates Ca2+ Entry in T Cells by Regulating miR-10a-5p. Frontiers in Immunology, 2019, 10(1737): 1-12.